We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
Men who have been forced by women to have sex against their will are being urged to take part in a new study into the "hidden crime".
A doctor has lost a Court of Appeal challenge against her gross negligence manslaughter conviction over the six-year-old's death.
Brexiteers are crowing "victory at last" over yesterday's overwhelming vote by MPs in favour of triggering Article 50 by the end of March.